Cargando…
Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases”
Autor principal: | Talotta, Rossella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833091/ https://www.ncbi.nlm.nih.gov/pubmed/33429060 http://dx.doi.org/10.1016/j.clim.2021.108665 |
Ejemplares similares
-
Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases
por: Vojdani, Aristo, et al.
Publicado: (2020) -
Reply to: Rethinking disease eradication: putting countries first
por: Hopkins, Donald R, et al.
Publicado: (2021) -
Autoimmunity as the comet tail of COVID-19 pandemic
por: Talotta, Rossella, et al.
Publicado: (2020) -
Molecular Mimicry and HLA Polymorphisms May Drive Autoimmunity in Recipients of the BNT-162b2 mRNA Vaccine: A Computational Analysis
por: Talotta, Rossella
Publicado: (2023) -
Impaired VEGF-A-Mediated Neurovascular Crosstalk Induced by SARS-CoV-2 Spike Protein: A Potential Hypothesis Explaining Long COVID-19 Symptoms and COVID-19 Vaccine Side Effects?
por: Talotta, Rossella
Publicado: (2022)